MDCXW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)0.0% YoY
Profit margin0.0%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-2865.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
-0.91

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Medicus Pharma Ltd. Warrant

Medicus Pharma Ltd. (MDCXW) is an emerging leader in the pharmaceutical industry dedicated to the development and commercialization of advanced therapies addressing critical healthcare needs. Leveraging a robust pipeline powered by innovative research methodologies and compliance with stringent regulatory standards, the company is strategically positioned to respond to the dynamic landscape of medical demands. Medicus Pharma is committed to enhancing patient outcomes and delivering sustainable long-term value for investors through its pioneering healthcare solutions.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
300 CONSHOHOCKEN STATE ROAD, WEST CONSHOHOCKEN, PA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$2.50
52W low$0.31

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer